ROS1-Mutated Inoperable Spindle Cell Sarcoma Treated With Repotrectinib—A Case Report
JCO Precision Oncology · 2026-06 · 10 (6)
DOI: 10.1200/po-25-01189 ↗Kurz gefasst
Fallbericht in der Zeitschrift JCO Precision Oncology, 2026-06. Verfasst von Christopher Rossmann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
- Division of General Radiological Diagnostics, Department of Radiology, Medical University of Graz, Graz, Austria.
- Diagnostic and Research Institute of Pathology, Medical University Graz, Graz, Austria.
ORCID-Profile: Jasminka Igrec, Georg Richtig
Zitieren
APA
Rossmann, C., Stotz, M., Igrec, J., Liegl-Atzwanger, B., Szkandera, J., & Richtig, G. (2026). ROS1-Mutated Inoperable Spindle Cell Sarcoma Treated With Repotrectinib—A Case Report. JCO Precision Oncology, 10(6). https://doi.org/10.1200/po-25-01189
Vancouver
Rossmann C, Stotz M, Igrec J, Liegl-Atzwanger B, Szkandera J, Richtig G. ROS1-Mutated Inoperable Spindle Cell Sarcoma Treated With Repotrectinib—A Case Report. JCO Precision Oncology. 2026;10(6). doi:10.1200/po-25-01189
BibTeX
@article{Rossmann2026,
author = {Rossmann, Christopher and Stotz, Michael and Igrec, Jasminka and Liegl-Atzwanger, Bernadette and Szkandera, Joanna and Richtig, Georg},
title = {ROS1-Mutated Inoperable Spindle Cell Sarcoma Treated With Repotrectinib—A Case Report},
journal = {JCO Precision Oncology},
year = {2026},
volume = {10},
number = {6},
doi = {10.1200/po-25-01189}
}
EUVIMED